Zura Bio (ZURA) Cash from Investing Activities (2022 - 2026)
Zura Bio's (ZURA) quarterly Cash from Investing Activities came in at -$13000.0 in Q1 2026, up 73.47% year-on-year from -$7494.1 in Q1 2025, and up 23.53% quarter-over-quarter from -$17000.0 in Q4 2025.
Zura Bio (ZURA) Cash from Investing Activities (2022 - 2026) Analysis & Trends
Zura Bio's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$13000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 73.47% year-over-year to -$13000.0 in Q1 2026; TTM through Mar 2026 was -$77000.0, a 34.19% increase from a year earlier, with the FY2025 full-year figure at -$113000.0, up 97.77% from the prior year.
- Cash from Investing Activities advanced to -$13000.0 in Q1 2026 per ZURA's latest filing, from -$17000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$10000.0 in Q2 2024 and bottomed at -$7.0 million in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$38500.0 (2024), against an average of -$1.6 million.
- Across the five-year window, Cash from Investing Activities surged 99.42% in 2024 and plunged 146.15% in 2025, its largest moves.
- Year by year, Cash from Investing Activities stood at -$7.0 million in 2022, then jumped by 67.86% to -$2.2 million in 2023, then jumped by 98.0% to -$45000.0 in 2024, then soared by 62.22% to -$17000.0 in 2025, then increased by 23.53% to -$13000.0 in 2026.
- Per Business Quant, the three latest ZURA Cash from Investing Activities figures stand at -$13000.0 (Q1 2026), -$17000.0 (Q4 2025), and -$32000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 172.62 Mn |
| 10 | Zura Bio | 609.93 Mn | 609.93 Mn | - | -13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13,000.00 |
| Mar 31, 2026 | -13,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Dec 31, 2025 | -17,000.00 |
| Sep 30, 2025 | -32,000.00 |
| Sep 30, 2025 | -32,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Jun 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -49,000.00 |
| Mar 31, 2025 | -49,000.00 |
| Dec 31, 2024 | -45,000.00 |
| Dec 31, 2024 | -45,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Sep 30, 2024 | -13,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Mar 31, 2024 | -5.01 Mn |
| Mar 31, 2024 | -5.01 Mn |
| Sep 30, 2023 | -2.25 Mn |
| Sep 30, 2023 | -2.25 Mn |